Nham Eliel, Noh Ji Yun, Park Ok, Choi Won Suk, Song Joon Young, Cheong Hee Jin, Kim Woo Joo
Division of Infectious Diseases, Department of Medicine, College of Medicine, Korea University, Seoul 02841, Republic of Korea.
Vaccine Innovation Center, Korea University, Seoul 02841, Republic of Korea.
Vaccines (Basel). 2024 May 9;12(5):514. doi: 10.3390/vaccines12050514.
Coronavirus disease 2019 (COVID-19) is a highly contagious zoonotic respiratory disease with many similarities to influenza. Effective vaccines are available for both; however, rapid viral evolution and waning immunity make them virtually impossible to eradicate with vaccines. Thus, the practical goal of vaccination is to reduce the incidence of serious illnesses and death. Three years after the introduction of COVID-19 vaccines, the optimal vaccination strategy in the endemic period remains elusive, and health authorities worldwide have begun to adopt various approaches. Herein, we propose a COVID-19 vaccination strategy based on the data available until early 2024 and discuss aspects that require further clarification for better decision making. Drawing from comparisons between COVID-19 and influenza vaccination strategies, our proposed COVID-19 vaccination strategy prioritizes high-risk groups, emphasizes seasonal administration aligned with influenza vaccination campaigns, and advocates the co-administration with influenza vaccines to increase coverage.
2019年冠状病毒病(COVID-19)是一种具有高度传染性的人畜共患呼吸道疾病,与流感有许多相似之处。两者都有有效的疫苗;然而,病毒的快速进化和免疫力的减弱使得几乎不可能通过疫苗根除它们。因此,疫苗接种的实际目标是降低严重疾病的发病率和死亡率。在COVID-19疫苗推出三年后,流行期的最佳疫苗接种策略仍然难以捉摸,全球卫生当局已开始采取各种方法。在此,我们根据截至2024年初的可用数据提出一种COVID-19疫苗接种策略,并讨论为更好地决策需要进一步澄清的方面。借鉴COVID-19和流感疫苗接种策略之间的比较,我们提出的COVID-19疫苗接种策略将高风险群体作为优先事项,强调与流感疫苗接种活动同步进行季节性接种,并提倡与流感疫苗联合接种以提高覆盖率。